L. Rauser et al., Inverse agonist actions of typical and atypical antipsychotic drugs at thehuman 5-hydroxytryptamine(2C) receptor, J PHARM EXP, 299(1), 2001, pp. 83-89
Citations number
48
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Atypical antipsychotic drugs, which are distinguished from typical antipsyc
hotic drugs by a lower incidence of extra-pyramidal side effects and less p
ropensity to elevate serum prolactin levels (e.g., clozapine, olanzapine, r
isperidone, quetiapine, ziprasidone), have become the most widely used trea
tments for schizophrenia, although their precise mechanism of action remain
s controversial. It has been suggested that this group of atypical antipsyc
hotic drugs is characterized by preferentially high affinities for 5-hydrox
ytryptamine (5-HT)(2A) serotonin receptors and relatively low affinities fo
r D2-dopamine receptors. It has recently been proposed that these atypical
antipsychotic drugs may also be distinguished from typical antipsychotic dr
ugs (e.g., haloperidol, fluphenazine, chlorpromazine, and so on) by inverse
agonist actions at the 5-HT2C-INI RNA edited isoform of the human 5-HT2C r
eceptor transiently expressed in COS-7 cells. We have examined the relation
ship among 5-HT2C inverse agonist potency, efficacy, and atypical antipsych
otic drug status in HEK-293 cells of a large number of typical and atypical
antipsychotic drugs using human embryonic kidney (HEK)-293 cells stably tr
ansfected with the h5-HT2C-INI receptor. Inverse agonist actions at h5-HT2C
-INI receptors were measured for both typical and atypical antipsychotic dr
ugs. Thus, some typical antipsychotic drugs (chlorpromazine, mesoridazine,
fluphenazine, and loxapine) were efficient inverse agonists, whereas severa
l clinically effective atypical antipsychotic drugs (remoxapride, quetiapin
e, sulpiride, melperone, amperozide) were not. Additionally, several drugs
without significant antipsychotic actions (M100907, ketanserin, mianserin,
ritanserin, and amitriptyline) were potent inverse agonists at the 5-HT2C-I
NI isoform expressed in HEK-293 cells. Taken together, these results demons
trate that both typical and atypical antipsychotic drugs may exhibit invers
e agonist effects at the 5-HT2C-INI isoform of the human 5-HT2C receptor an
d that no relationship exists between inverse agonist actions and atypicali
ty.